BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24389893)

  • 1. Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma.
    Wang SY; Kuai XP; Meng XX; Jia NY; Dong H
    Abdom Imaging; 2014 Apr; 39(2):323-33. PubMed ID: 24389893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of triple-phase CT findings for the differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular carcinoma in non-cirrhotic liver.
    Jeon TY; Kim SH; Lim HK; Lee WJ
    Eur J Radiol; 2010 Mar; 73(3):601-6. PubMed ID: 19200676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic angiomyolipoma: CT and MR imaging findings with clinical-pathologic comparison.
    Cai PQ; Wu YP; Xie CM; Zhang WD; Han R; Wu PH
    Abdom Imaging; 2013 Jun; 38(3):482-9. PubMed ID: 22996326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients.
    Ding H; Wei H; Liu H; Chen Y; Xue X; Weng H
    Ann Hepatol; 2017; 16(5):759-764. PubMed ID: 28809731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Angiomyolipoma Versus Hepatocellular Carcinoma in the Noncirrhotic Liver on Gadoxetic Acid-Enhanced MRI: A Diagnostic Challenge.
    Lee SJ; Kim SY; Kim KW; Kim JH; Kim HJ; Lee MG; Yu ES
    AJR Am J Roentgenol; 2016 Sep; 207(3):562-70. PubMed ID: 27248975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ADC measurement in differential diagnosis of focal hepatic lesions.
    Onur MR; Çiçekçi M; Kayalı A; Poyraz AK; Kocakoç E
    Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
    Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
    AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiomyolipoma of the liver: analysis of typical features and pitfalls based on own experience and literature.
    Anysz-Grodzicka A; Pacho R; Grodzicki M; Koperski L; Górnicka B; Cieszanowski A; Zieniewicz K; Krawczyk M
    Clin Imaging; 2013; 37(2):320-6. PubMed ID: 23465986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Mizuno N; Kawada H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.
    Park MJ; Kim YK; Park HJ; Hwang J; Lee WJ
    J Comput Assist Tomogr; 2013; 37(6):872-81. PubMed ID: 24270108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced sonographic appearances of two primary hepatic epithelioid angiomyolipomas.
    Chai V; Fox A; Chong L; House E; Sutherland T
    J Clin Ultrasound; 2020 Jun; 48(5):283-286. PubMed ID: 32012287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelioid angiomyolipoma of the liver: cross-sectional imaging findings of 10 immunohistochemically-verified cases.
    Xu PJ; Shan Y; Yan FH; Ji Y; Ding Y; Zhou ML
    World J Gastroenterol; 2009 Sep; 15(36):4576-81. PubMed ID: 19777618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.